BackBioray Biotech , Ltd Overview

Bioray Biotech , Ltd Receivables

Latest receivables for 7561.TWO: $41M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$40.55M
↓ 35.77% YoYΔ $-22.58M vs prior year quarter

Peer trimmed avg / median

Loading

Bioray Biotech , Ltd Receivables History

Loading

Bioray Biotech , Ltd vs. peers: Receivables Comparison

Loading

Bioray Biotech , Ltd Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Bioray Biotech , Ltd (7561.TWO) FAQ

Bioray Biotech , Ltd (7561.TWO) currently reports a receivables of $41M as of June 2026. That compares with $63M in the prior-year period — down 35.8% year over year. Use the charts on this page to explore Bioray Biotech , Ltd's receivables history and peer comparisons.

Bioray Biotech , Ltd's receivables decreased from $63M to $41M — a 35.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bioray Biotech , Ltd reported $41M in receivables as of June 2026. That compares with $63M in the prior-year period — down 35.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $41M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bioray Biotech , Ltd, and consider following 7561.TWO for alerts when major investors trade the stock.